Skip to main content

Frank Curzio, portfolio manager of

Stocks Under $10

, shows you how to profit off of fear and forced selling.

Watch his video to see how he's playing the market during this volatile earnings season. See how Curzio will make money off of numbers from

Caterpillar

(CAT)

,

Intel

(INTC)

and

General Electric

(GE)

.

var config = new Array(); config<BRACKET>"videoId"</BRACKET> = 20916994001; config<BRACKET>"playerTag"</BRACKET> = "TSCM Embedded Video Player"; config<BRACKET>"autoStart"</BRACKET> = false; config<BRACKET>"preloadBackColor"</BRACKET> = "#FFFFFF"; config<BRACKET>"useOverlayMenu"</BRACKET> = "false"; config<BRACKET>"width"</BRACKET> = 265; config<BRACKET>"height"</BRACKET> = 255; config<BRACKET>"playerId"</BRACKET> = 1243645856; createExperience(config, 8);

News of the Week

Image placeholder title

Epiq Systems

(EPIQ)

, which Curzio owns for his portfolio, reported worse-than-expected first-quarter earnings of 16 cents a share. The company's bankruptcy unit and eDiscovery segment were strong and reported gains. The stock was trading 12% lower at $14.12.

Imax

(IMAX)

got a thumbs up from

The Wall Street Journal

this week for focusing on digital technology rather than more expensive film prints and projections. The company also announced an agreement with the

China Film Group

to open an IMAX theater in China. The stock jumped almost 7% to $6.25.

Two biopharmaceuticals struggled this week.

Kendle

( KNDL) announced that its earnings will be much lower than estimated due to project cancellations and delays. Shares were down more than 8% to $10.10.

Bad news also plagued competitor

Parexel

(PRXL)

, which saw its shares fall 20 %. Parexel is scheduled to report its third-quarter earnings on Tuesday.

King Pharmaceuticals

( KG) received an upgrade from

UBS

(UBS)

to buy from sell and

RBC Capital Markets

initiated coverage with a sector perform rating. Shares were trading down more than 2% at $8.03.

Week Ahead

On the economic front, GDP data, factory orders and personal income will be market movers as investors try to gauge if the worst is over.

Image placeholder title

On the earnings front, many small-cap and under-$10 names still have to report. Analysts are looking to see how management teams are dealing with this economic crisis.

Over in Washington, the government will release the results of its stress tests for 19 of the nation's biggest banks and lenders will have an opportunity to debate the findings. Although the list of banks under scrutiny has not been officially released, most likely investors will see results from several banks under $10:

Citigroup

(C)

,

Bank of America

(BAC)

,

Keycorp

(KEY)

,

Regions Financial

(RF)

and

Fifth Third Bancorp

(FITB)

.

Tune into The Real Story podcast where Frank takes you beyond the headlines to tell you what's really going on in the market.

Click here to subscribe to the podcast today!

This week one listener who recently signed up for Curzio's Stocks Under $10 portfolio inquired about appropriate reading material.

Curzio recommends listening to as many conference calls as possible during earnings season. Newbie investors should start with infrastructure companies like

McDermott

(MDR)

and

Foster Wheeler

undefined

then progress into bigger names like

IBM

(IBM)

,

Google

(GOOG)

and

Apple

(AAPL)

.

Most important, focus on how each company is dealing with the downturn, what management teams are forecasting for the next year, which business segments are strong and which areas of the world are strong.

Alix joined TheStreet.com TV in February 2007. Previously, she held positions in film and theater production, management, and legal administration. Alix has a degree in communications and theater from Northwestern University.